ES2082973T3 - Dispositivo para administracion iontoforetica de farmacos. - Google Patents

Dispositivo para administracion iontoforetica de farmacos.

Info

Publication number
ES2082973T3
ES2082973T3 ES91907000T ES91907000T ES2082973T3 ES 2082973 T3 ES2082973 T3 ES 2082973T3 ES 91907000 T ES91907000 T ES 91907000T ES 91907000 T ES91907000 T ES 91907000T ES 2082973 T3 ES2082973 T3 ES 2082973T3
Authority
ES
Spain
Prior art keywords
active
active agent
hydrogel
iontophoretical
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91907000T
Other languages
English (en)
Inventor
Joseph Bradley Phipps
Warren W Howland
Allan H Jevne
Carolann Holmblad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2082973T3 publication Critical patent/ES2082973T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J133/00—Adhesives based on homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Adhesives based on derivatives of such polymers
    • C09J133/24—Homopolymers or copolymers of amides or imides
    • C09J133/26—Homopolymers or copolymers of acrylamide or methacrylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2666/00—Composition of polymers characterized by a further compound in the blend, being organic macromolecular compounds, natural resins, waxes or and bituminous materials, non-macromolecular organic substances, inorganic substances or characterized by their function in the composition
    • C08L2666/02—Organic macromolecular compounds, natural resins, waxes or and bituminous materials
    • C08L2666/04—Macromolecular compounds according to groups C08L7/00 - C08L49/00, or C08L55/00 - C08L57/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Electrotherapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Two-Way Televisions, Distribution Of Moving Picture Or The Like (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE PRESENTA UN DISPOSITIVO IONTOFORETICO QUE TIENE UN ELECTRODO ACTIVO DE DOS CAPAS (20). EL ELEMENTO ACTIVO ESTA COMPUESTO DE UN HIDROGEL DE CONTACTO (21) QUE SE SUPERPONE A LA PIEL Y CAPAS PORTADORAS (22). LA CAPA PORTADORA CONTIENE UN AGENTE ACTIVO DISPERSO O DISUELTO. EL ELECTRODO ACTIVO MANTIENE AL AGENTE ACTIVO EN FORMA ESTABLE Y PERMITE UN TRANSPORTE EFICIENTE DEL AGENTE ACTIVO HASTA EL RECEPTOR. TAMBIEN SE PRESENTA UN DISPOSITIVO IONTOFORETICO QUE TIENE UN ELECTRODO ACTIVO DE CAPA SIMPLE. LA CAPA SIMPLE ES UN HIDROGEL MANUFACTURADO O SUBSTANCIALMENTE SECO Y CAPAZ DE SER HIDRATADO ANTES DE SU USO. EL HIDROGEL DE CONTACTO CON LA PIEL DEL ELECTRODO ACTIVO DE DOS CAPAS ES PREFERIBLEMENTE ADHESIVO.
ES91907000T 1990-03-30 1991-03-26 Dispositivo para administracion iontoforetica de farmacos. Expired - Lifetime ES2082973T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50284190A 1990-03-30 1990-03-30
US67531391A 1991-03-26 1991-03-26

Publications (1)

Publication Number Publication Date
ES2082973T3 true ES2082973T3 (es) 1996-04-01

Family

ID=27054298

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91907000T Expired - Lifetime ES2082973T3 (es) 1990-03-30 1991-03-26 Dispositivo para administracion iontoforetica de farmacos.

Country Status (12)

Country Link
US (2) US5423739A (es)
EP (1) EP0521988B1 (es)
AT (1) ATE131392T1 (es)
AU (1) AU657681B2 (es)
CA (1) CA2079315C (es)
DE (1) DE69115471T2 (es)
DK (1) DK0521988T3 (es)
ES (1) ES2082973T3 (es)
FI (1) FI924382A0 (es)
IE (1) IE74127B1 (es)
NO (1) NO923770L (es)
PT (1) PT97217B (es)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69115471T2 (de) * 1990-03-30 1996-05-02 Alza Corp., Palo Alto, Calif. Gerät zur iontophoretischen verabreichung von medikamenten
CA2187023A1 (en) * 1994-04-13 1995-10-26 Steven Andrew Giannos Temporally controlled drug delivery systems
CA2154928C (en) * 1994-08-19 2000-01-04 Katherine Louise Mayer Body fitting compound sanitary napkin
JPH08155041A (ja) * 1994-12-05 1996-06-18 Advance Co Ltd イオントフォレシス用新規高能率電極システム
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
ZA964320B (en) * 1995-06-05 1997-01-13 Alza Corp Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6881208B1 (en) * 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US5840056A (en) * 1995-06-15 1998-11-24 Empi, Inc. Iontophoresis electrode
US5788666A (en) * 1995-06-15 1998-08-04 Empi, Inc. Iontophoresis electrode
US5989409A (en) * 1995-09-11 1999-11-23 Cygnus, Inc. Method for glucose sensing
WO1997048443A1 (en) * 1996-06-19 1997-12-24 Becton Dickinson And Company Iontophoretic delivery of cell adhesion inhibitors
US5871461A (en) * 1996-07-12 1999-02-16 Empi, Inc. Method of making an iontophoresis electrode
US5857993A (en) * 1996-07-12 1999-01-12 Empi, Inc. Process of making an iontophoresis electrode
US5941843A (en) * 1996-07-12 1999-08-24 Empi, Inc. Iontophoresis electrode
US5797867A (en) * 1996-09-27 1998-08-25 Becton Dickinson And Company Iontophoretic drug delivery system, including method for activating same for attachment to patient
US6246904B1 (en) * 1996-12-17 2001-06-12 Alza Corporation Electrotransport drug delivery reservoirs containing inert fillers
AU722574B2 (en) 1996-12-20 2000-08-10 Alza Corporation Device and method for enhancing transdermal agent flux
US6139718A (en) 1997-03-25 2000-10-31 Cygnus, Inc. Electrode with improved signal to noise ratio
US6119036A (en) 1997-03-26 2000-09-12 The Board Of Regents Of The University Of Oklahoma Iontophoretic transdermal delivery device
CA2308489A1 (en) 1997-10-09 1999-04-22 Emory University Method and devices for transdermal delivery of lithium
US6918901B1 (en) 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
WO1999029364A1 (en) * 1997-12-11 1999-06-17 Alza Corporation Device for enhancing transdermal agent flux
EP1911488A3 (en) 1997-12-11 2008-12-03 Alza Corporation Device for enhancing transdermal agent flux
PT1037686E (pt) * 1997-12-11 2005-10-31 Alza Corp Aparelho para potenciar o fluxo de agente transdermico
CN1206004C (zh) 1997-12-11 2005-06-15 阿尔扎有限公司 增强透皮物剂流量的装置
US6163720A (en) * 1997-12-18 2000-12-19 Alza Corporation Layered rate controlling membranes for use in an electrotransport device
US6096726A (en) 1998-03-11 2000-08-01 Surface Solutions Laboratories Incorporated Multicomponent complex for use with substrate
US6117296A (en) * 1998-07-21 2000-09-12 Thomson; Timothy Electrically controlled contractile polymer composite
US20050147690A1 (en) * 1998-09-25 2005-07-07 Masters David B. Biocompatible protein particles, particle devices and methods thereof
US7662409B2 (en) * 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
JP2002536133A (ja) 1999-02-10 2002-10-29 ジーエムピー ドラッグ デリバリー インコーポレイテッド 局所薬物送達用のイオン導入パッチ、電気穿孔パッチおよび併用パッチ
ATE310561T1 (de) 1999-12-10 2005-12-15 Alza Corp Vorrichtung und verfahren zur verbesserung des mikronadel-haut-piercing
JP2003522613A (ja) 2000-02-18 2003-07-29 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション 交流を用いて物質を抽出する方法
CA2400325A1 (en) 2000-02-18 2001-08-23 University Of Utah Research Foundation Methods for delivering agents using alternating current
WO2001076553A2 (en) * 2000-04-06 2001-10-18 Sontra Medical, Inc. Method and device for enhanced transdermal drug delivery
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
US7572288B2 (en) * 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
DE10141254C1 (de) * 2001-08-23 2003-04-03 Susann Edel Iontophorese-Kaltkontaktelektrodensystem zur gleichzeitigen Anwendung der Kühlung und der Iontophorese
US8623393B2 (en) * 2002-04-29 2014-01-07 Gel-Del Technologies, Inc. Biomatrix structural containment and fixation systems and methods of use thereof
US20040015145A1 (en) * 2002-07-16 2004-01-22 The Procter & Gamble Company Absorbent article having a graphic visible through body contacting surface
AU2003282683A1 (en) * 2002-10-04 2004-05-04 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
WO2004057057A1 (en) * 2002-12-23 2004-07-08 Council Of Scientific And Industrial Research Process for manufacture of proton conductive polymer gel useful as backfill for sacrificial and impressed current anode systems
US8465537B2 (en) * 2003-06-17 2013-06-18 Gel-Del Technologies, Inc. Encapsulated or coated stent systems
US8153591B2 (en) * 2003-08-26 2012-04-10 Gel-Del Technologies, Inc. Protein biomaterials and biocoacervates and methods of making and using thereof
WO2005055945A2 (en) * 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
WO2006055729A1 (en) * 2004-11-16 2006-05-26 Transcutaneous Technologies Inc. Iontophoretic device and method for administering immune response-enhancing agents and compositions
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US8295922B2 (en) 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
US20070088332A1 (en) * 2005-08-22 2007-04-19 Transcutaneous Technologies Inc. Iontophoresis device
JPWO2007023907A1 (ja) * 2005-08-24 2009-02-26 Ｔｔｉ・エルビュー株式会社 冷凍型イオントフォレーシス用電極構造体
US20070048362A1 (en) * 2005-08-29 2007-03-01 Transcutaneous Technologies Inc. General purpose electrolyte solution composition for iontophoresis
CN101252968A (zh) 2005-09-15 2008-08-27 Tti优而美株式会社 棒式离子电渗疗装置
EP1931417A2 (en) * 2005-09-30 2008-06-18 Transcutaneous Technologies Inc. Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
JP2009509676A (ja) * 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 ナノ粒子と接合された活性物質のイオントフォレーシス送達
WO2007041526A2 (en) * 2005-09-30 2007-04-12 Transcutaneous Technologies Inc. Iontophoresis apparatus and method to deliver antibiotics to biological interfaces
WO2007041323A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic delivery of vesicle-encapsulated active agents
CA2664589A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
KR20080066712A (ko) * 2005-09-30 2008-07-16 티티아이 엘뷰 가부시키가이샤 관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
US20070083185A1 (en) * 2005-09-30 2007-04-12 Darrick Carter Iontophoretic device and method of delivery of active agents to biological interface
JP2009522011A (ja) * 2005-12-30 2009-06-11 Ｔｔｉ・エルビュー株式会社 活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法
US20080004564A1 (en) * 2006-03-30 2008-01-03 Transcutaneous Technologies Inc. Controlled release membrane and methods of use
CN101522255A (zh) * 2006-09-29 2009-09-02 皇家飞利浦电子股份有限公司 用于经过皮的药物传送系统的电气激活凝胶阵列
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
BRPI0719353A2 (pt) 2006-12-01 2014-01-07 Titi Ellebeau Inc Sistemas, dispositivos e métodos para dispositivos de energização e/ou controle, por exemplo, dispositivos de distribuição transdérmicos
JPWO2008087803A1 (ja) * 2007-01-16 2010-05-06 国立大学法人北海道大学 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
EP2162101B1 (en) 2007-06-25 2019-02-20 MicroVention, Inc. Self-expanding prosthesis
CA2724949A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodynamic therapy
US8180446B2 (en) 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method and system for cyclical neural modulation based on activity state
US8989858B2 (en) 2007-12-05 2015-03-24 The Invention Science Fund I, Llc Implant system for chemical modulation of neural activity
US8195287B2 (en) 2007-12-05 2012-06-05 The Invention Science Fund I, Llc Method for electrical modulation of neural conduction
US8165668B2 (en) 2007-12-05 2012-04-24 The Invention Science Fund I, Llc Method for magnetic modulation of neural conduction
US8165669B2 (en) 2007-12-05 2012-04-24 The Invention Science Fund I, Llc System for magnetic modulation of neural conduction
US8180447B2 (en) 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method for reversible chemical modulation of neural activity
US8170658B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for electrical modulation of neural conduction
US8170660B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for thermal modulation of neural activity
WO2009086483A2 (en) * 2007-12-26 2009-07-09 Gel-Del Technologies, Inc. Biocompatible protein particles, particle devices and methods thereof
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
ES2639576T3 (es) 2008-06-19 2017-10-27 Lts Lohmann Therapie-Systeme Ag Composición para administración transdérmica de agentes activos catiónicos
US20100022494A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and kit for maintaining physiological levels of steroid hormone in a subject
US20100022487A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and kit for maintaining physiological levels of steroid hormone in a subject
US20100022497A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject
WO2010057177A2 (en) 2008-11-17 2010-05-20 Gel-Del Technologies, Inc. Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
US20110092881A1 (en) * 2009-05-08 2011-04-21 Isis Biopolymer Inc. Iontophoretic device with contact sensor
WO2010129928A1 (en) * 2009-05-08 2010-11-11 Isis Biopolymer Llc Iontophoretic device with improved counterelectrode
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
CA2780274C (en) 2009-11-09 2018-06-26 Spotlight Technology Partners Llc Fragmented hydrogels
USD678534S1 (en) 2010-07-20 2013-03-19 Iontera, Inc. Iontophoretic device for application to the brow/forehead of a person
WO2012155093A1 (en) 2011-05-11 2012-11-15 Microvention, Inc. Device for occluding a lumen
EP2886153A1 (de) 2013-12-20 2015-06-24 LTS LOHMANN Therapie-Systeme AG System für die transdermale Abgabe von Wirkstoff
EP3181117A1 (en) * 2015-12-15 2017-06-21 L'oreal Vitamin c composition and an iontophoresis method for its delivery
US12296129B2 (en) 2018-03-07 2025-05-13 Soovu Labs, Inc. Systems and methods for improved pain relief from stimulation of thermal fibers

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998215A (en) * 1968-12-18 1976-12-21 Minnesota Mining And Manufacturing Company Bio-medical electrode conductive gel pads
CS159361B1 (es) * 1970-09-08 1975-01-31
CS164542B1 (es) * 1973-02-15 1975-11-07
US3991755A (en) * 1973-07-27 1976-11-16 Medicon, Inc. Iontophoresis apparatus for applying local anesthetics
US3929741A (en) * 1974-07-16 1975-12-30 Datascope Corp Hydrophilic acrylamido polymers
US4094822A (en) * 1974-12-26 1978-06-13 Kater John A R Bio-event electrode material
US3994302A (en) * 1975-08-14 1976-11-30 Medtronic, Inc. Stimulation electrode of ion-exchange material
US4051842A (en) * 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
US4274420A (en) * 1975-11-25 1981-06-23 Lectec Corporation Monitoring and stimulation electrode
US4066078A (en) * 1976-02-05 1978-01-03 Johnson & Johnson Disposable electrode
DE2626348C3 (de) * 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4141359A (en) * 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4352359A (en) * 1977-08-19 1982-10-05 Minnesota Mining And Manufacturing Company Biomedical electrode
US4273135A (en) * 1977-08-19 1981-06-16 Minnesota Mining And Manufacturing Company Biomedical electrode
CA1153427A (en) * 1978-12-11 1983-09-06 Patrick T. Cahalan Tape electrode
GB2046764B (en) * 1979-02-08 1983-04-20 Matburn Holdings Ltd Polymeric sealant compositions
US4524087A (en) * 1980-01-23 1985-06-18 Minnesota Mining And Manufacturing Company Conductive adhesive and biomedical electrode
US4383529A (en) * 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4820263A (en) * 1981-03-06 1989-04-11 Medtronic, Inc. Apparatus and method for iontophoretic drug delivery
US4768523A (en) * 1981-04-29 1988-09-06 Lifecore Biomedical, Inc. Hydrogel adhesive
JPS5810066A (ja) * 1981-07-10 1983-01-20 株式会社アドバンス イオントフオレ−ゼ用プラスタ−構造体
US4419092A (en) * 1981-11-06 1983-12-06 Motion Control, Inc. Iontophoretic electrode structure
US4693711A (en) * 1981-12-22 1987-09-15 Bremer Roger E Long-life biomedical transcutaneous drug application device and method of transcutaneous application of drugs
US4526176A (en) * 1981-12-22 1985-07-02 Frantz Medical Development Ltd. Long-life biomedical application device, particularly electrode, and method of transferring electrical current
US4699146A (en) * 1982-02-25 1987-10-13 Valleylab, Inc. Hydrophilic, elastomeric, pressure-sensitive adhesive
US4557723A (en) * 1983-08-18 1985-12-10 Drug Delivery Systems Inc. Applicator for the non-invasive transcutaneous delivery of medicament
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4708716A (en) * 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs
US4601286A (en) * 1984-04-20 1986-07-22 Kaufman Jack W Article for the protection of living tissues
US4744787A (en) * 1984-10-29 1988-05-17 Medtronic, Inc. Iontophoresis apparatus and methods of producing same
US4747819A (en) * 1984-10-29 1988-05-31 Medtronic, Inc. Iontophoretic drug delivery
CA1267937A (en) * 1984-10-29 1990-04-17 Joseph Bradley Phipps Iontophoretic drug delivery
US4655767A (en) * 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4585652A (en) * 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
GB8509978D0 (en) * 1985-04-18 1985-05-30 Juhasz L Wound dressings
US4645502A (en) * 1985-05-03 1987-02-24 Alza Corporation Transdermal delivery of highly ionized fat insoluble drugs
DE3533114A1 (de) * 1985-09-17 1987-03-26 Berolina Kunststoff Teilbarer flaschenkasten
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4734090A (en) * 1986-07-18 1988-03-29 Drug Delivery Systems Inc. Electrical transdermal drug applicator
JPS63102768A (ja) * 1986-10-20 1988-05-07 山之内製薬株式会社 イオントフオレ−シス用の新規プラスタ−構造体
GB2204497B (en) * 1986-11-21 1991-02-27 Univ Boston Electrode assembly for transdermal drug delivery
US4786277A (en) * 1986-11-21 1988-11-22 Trustees Of Boston University Electrodes, electrode assemblies, methods, and systems for tissue stimulation
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
EP0318776A1 (en) * 1987-12-04 1989-06-07 Robert Tapper Method and apparatus for minimizing skin injury with electrode use
US4814168A (en) * 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
IL86076A (en) * 1988-04-14 1992-12-01 Inventor S Funding Corp Ltd Transdermal drug delivery device
US4927408A (en) * 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5057072A (en) * 1988-10-28 1991-10-15 Medtronic, Inc. Iontophoresis electrode
US5084008A (en) * 1989-12-22 1992-01-28 Medtronic, Inc. Iontophoresis electrode
US5084006A (en) * 1990-03-30 1992-01-28 Alza Corporation Iontopheretic delivery device
DE69115471T2 (de) * 1990-03-30 1996-05-02 Alza Corp., Palo Alto, Calif. Gerät zur iontophoretischen verabreichung von medikamenten

Also Published As

Publication number Publication date
EP0521988A1 (en) 1993-01-13
CA2079315C (en) 2003-04-15
AU7565291A (en) 1991-10-30
PT97217A (pt) 1992-01-31
US5423739A (en) 1995-06-13
DE69115471D1 (de) 1996-01-25
DE69115471T2 (de) 1996-05-02
PT97217B (pt) 1998-11-30
ATE131392T1 (de) 1995-12-15
NO923770D0 (no) 1992-09-28
AU657681B2 (en) 1995-03-23
CA2079315A1 (en) 1991-10-01
IE74127B1 (en) 1997-07-02
EP0521988B1 (en) 1995-12-13
FI924382A7 (fi) 1992-09-29
FI924382A0 (fi) 1992-09-29
US5558633A (en) 1996-09-24
NO923770L (no) 1992-11-30
IE911082A1 (en) 1991-10-09
DK0521988T3 (da) 1996-04-29

Similar Documents

Publication Publication Date Title
DK0521988T3 (da) Anordning til iontoforetisk lægemiddeltilførsel
ES2055692T3 (es) Sistema terapeutico en forma plana, procedimiento para su preparacion y su empleo.
SE8605383L (sv) Flerfaldigt indelade transdermala och dermala plaster
ES2073401T3 (es) Apositos adhesivos que contienen un ingrediente farmaceuticamente activo.
ES2040588T5 (es) Un pañal higienico o proteccion de incontinencia.
ATE14527T1 (de) Auftragsvorrichtung fuer pharmazeutische wirkstoffe, ihre herstellung und gebrauch.
ES2175792T3 (es) Sistema de administracion transdermica con capa reservorio adhesiva de contacto y capa superior elastica unidireccional.
ES2054705T3 (es) Articulo desechable absorbente de liquido.
CA2229185A1 (en) Plaster structure for iontophoresis
CO4650262A1 (es) Articulos absorbentes que tienen propiedades mejoradas
DE69330710D1 (de) Elektrode und gebrauchsfertige Schicht vom Gel zum Verwenden mit einer Elektrode
ATE65181T1 (de) Pharmazeutische orale formulierung mit mehrfachen einheiten, mit kontrollierter freisetzung.
ES2101086T3 (es) Aposito de cateter de vena con ventana.
MY146030A (en) Absorbent article containing skin-protective ingredient
MY111126A (en) Transdermal therapeutic system comprising the active substance acetylsalicylic acid.
ES2148470T3 (es) Farmaco analgesico antipiretico combinado.
ES2063401T3 (es) Rulo adherente para rizar el cabello humano.
ES2095216T3 (es) Sistema transdermal con cesion escalonada del principio activo y su empleo para la administracion cosmetica local o sistemica del principio activo.
GB2020181A (en) Improved delivery system
MX146775A (es) Mejoras en procedimiento y dispositivo para la flexibilizacion o el aflojamiento de cuero
NO894467D0 (no) Reservoar for styrt frigjoering av aktive substanser, anordning som inneholder den, fremgangsmaate for aa fremstille den, og bruk av anordningen.
ES2021129B3 (es) Procedimiento y dispositivo para el tratamiento discontinuo de la humedad en material textil
AR244133A1 (es) Dispositivo almacenador y dispensador de liquidos.
ES2317524T3 (es) Neceser y procedimiento para la proteccion de apositos y/o de zonas cutaneas heridas del cuerpo.
NO970553D0 (no) Östradiolinneholdende transdermale terapeutiske systemer omfattende hydrofile tilsetningsstoffer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 521988

Country of ref document: ES